Clinical Utility of Biosensing Platforms for Confirmation of SARS-CoV-2 Infection
Autor: | Thi-Thu Pham, My-Van Tieu, Le Minh Tu Phan, Sungbo Cho |
---|---|
Rok vydání: | 2021 |
Předmět: |
Coronavirus disease 2019 (COVID-19)
Computer science viruses Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Point-of-care testing Clinical Biochemistry RT-PCR Biomedical Engineering Enzyme-Linked Immunosorbent Assay Review Biosensing Techniques 02 engineering and technology Diagnostic tools Analytical Chemistry 03 medical and health sciences COVID-19 Testing Pandemic Animals Humans Instrumentation Engineering (miscellaneous) RT-LAMP 030304 developmental biology Strategic planning 0303 health sciences optical biosensor lab-in-a-tube SARS-CoV-2 lateral flow assay Electrochemical Techniques Equipment Design General Medicine Nucleic acid amplification technique 021001 nanoscience & nanotechnology nucleic acid amplification electrochemical biosensor Risk analysis (engineering) Point-of-Care Testing Clinical diagnosis ELISA Colorimetry COVID-19 clinical diagnostics 0210 nano-technology Nucleic Acid Amplification Techniques TP248.13-248.65 Biotechnology |
Zdroj: | Biosensors Biosensors, Vol 11, Iss 167, p 167 (2021) |
ISSN: | 2079-6374 |
DOI: | 10.3390/bios11060167 |
Popis: | Despite collaborative efforts from all countries, coronavirus disease 2019 (COVID-19) pandemic has been continuing to spread globally, forcing the world into social distancing period, making a special challenge for public healthcare system. Before vaccine widely available, the best approach to manage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is to achieve highest diagnostic accuracy by improving biosensor efficacy. For SARS-CoV-2 diagnostics, intensive attempts have been made by many scientists to ameliorate the drawback of current biosensors of SARS-CoV-2 in clinical diagnosis to offer benefits related to platform proposal, systematic analytical methods, system combination, and miniaturization. This review assesses ongoing research efforts aimed at developing integrated diagnostic tools to detect RNA viruses and their biomarkers for clinical diagnostics of SARS-CoV-2 infection and further highlights promising technology for SARS-CoV-2 specific diagnosis. The comparisons of SARS-CoV-2 biomarkers as well as their applicable biosensors in the field of clinical diagnosis were summarized to give scientists an advantage to develop superior diagnostic platforms. Furthermore, this review describes the prospects for this rapidly growing field of diagnostic research, raising further interest in analytical technology and strategic plan for future pandemics. |
Databáze: | OpenAIRE |
Externí odkaz: |